The 10-Year Extended Follow-up of the DACAB Trial
NCT07480629
·
clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
500
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
CABG
Antiplatelet Therapy of Coronary Artery Bypass
Sponsor
Ruijin Hospital